Detalles de la búsqueda
1.
METTL3 as a novel diagnosis and treatment biomarker and its association with glycolysis, cuproptosis and ceRNA in oesophageal carcinoma.
J Cell Mol Med
; 28(6): e18195, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38429907
2.
DARS2 overexpression is associated with PET/CT metabolic parameters and affects glycolytic activity in lung adenocarcinoma.
J Transl Med
; 21(1): 574, 2023 08 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37626419
3.
High expression of HNRNPR in ESCA combined with 18F-FDG PET/CT metabolic parameters are novel biomarkers for preoperative diagnosis of ESCA.
J Transl Med
; 20(1): 450, 2022 10 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36195940
4.
Effects of miR-362 in Regulating the Proliferation, Invasion and Apoptosis of Gastric Cancer by Inhibiting the Expression of Tumor-Promoting Factor PRDM2.
Crit Rev Eukaryot Gene Expr
; 31(1): 11-21, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33639051
5.
Nucleophosmin 1 overexpression correlates with 18F-FDG PET/CT metabolic parameters and improves diagnostic accuracy in patients with lung adenocarcinoma.
Eur J Nucl Med Mol Imaging
; 48(3): 904-912, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32856112
6.
Uterine Burkitt Lymphoma with Rare Extranodal Deposits in the Bone, Breast, and Sacral Canal: A Case Report.
Onco Targets Ther
; 17: 41-44, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38298550
7.
TRIP6 a potential diagnostic marker for colorectal cancer with glycolysis and immune infiltration association.
Sci Rep
; 14(1): 4042, 2024 02 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38369589
8.
Pan-cancer analysis reveals correlation between RAB3B expression and tumor heterogeneity, immune microenvironment, and prognosis in multiple cancers.
Sci Rep
; 14(1): 9881, 2024 04 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38688977
9.
Functional enrichment analysis reveals the involvement of DARS2 in multiple biological pathways and its potential as a therapeutic target in esophageal carcinoma.
Aging (Albany NY)
; 16(4): 3934-3954, 2024 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38382106
10.
SPC25 as a novel therapeutic and prognostic biomarker and its association with glycolysis, ferroptosis and ceRNA in lung adenocarcinoma.
Aging (Albany NY)
; 16(1): 779-798, 2024 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38217547
11.
SFXN1 as a potential diagnostic and prognostic biomarker of LUAD is associated with 18F-FDG metabolic parameters.
Lung Cancer
; 188: 107449, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38184958
12.
DARS2 is a prognostic biomarker and correlated with immune infiltrates and cuproptosis in lung adenocarcinoma.
Am J Cancer Res
; 13(3): 818-834, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37034224
13.
Magnetic resonance imaging and 18F-fludeoxyglucose positron emission tomography/computed tomography findings of retroperitoneal clear cell carcinoma with an unknown primary site: A case report.
Front Med (Lausanne)
; 9: 1024008, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36388941
14.
Situs Inversus Totalis on 18F-FDG PET/CT: A Case Report and a Literature Review.
Front Med (Lausanne)
; 9: 840795, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35355611
15.
ECE2 is a prognostic biomarker associated with m6A modification and involved in immune infiltration of lung adenocarcinoma.
Front Endocrinol (Lausanne)
; 13: 1013238, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36299451
16.
Nucleophosmin 1 is a prognostic marker of gastrointestinal cancer and is associated with m6A and cuproptosis.
Front Pharmacol
; 13: 1010879, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36188614
17.
Comprehensive Analysis of YTHDF1 Immune Infiltrates and ceRNA in Human Esophageal Carcinoma.
Front Genet
; 13: 835265, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35401696
18.
SLC2A1 is a Diagnostic Biomarker Involved in Immune Infiltration of Colorectal Cancer and Associated With m6A Modification and ceRNA.
Front Cell Dev Biol
; 10: 853596, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35399515
19.
Comprehensive Analysis of SLC17A9 and Its Prognostic Value in Hepatocellular Carcinoma.
Front Oncol
; 12: 809847, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35957868
20.
Corrigendum: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
Front Immunol
; 12: 751004, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34531879